Chen Tian, Zhou Shulin, Zhang Yashuang, Meng Huangyang, Miao Huixian, Feng Mingming, Jiang Yi, Wan Yicong, Zhang Lin, Cheng Wenjun
Department of Gynecology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, Jiangsu, China.
Int J Biol Sci. 2025 Aug 30;21(12):5531-5546. doi: 10.7150/ijbs.112615. eCollection 2025.
The absence of cytotoxic effector cells, such as CD8⁺ T cells or Natural Killer (NK) cells, within tumors establishes an immune-cold tumor microenvironment (TME), contributing to poor immunotherapy responses, as observed in ovarian cancer. Although prior studies implicate NK cell exhaustion within the TME related to ferroptosis, the underlying mechanisms remain undefined. This study demonstrates that upon infiltrating the ovarian cancer TME, NK cells activate an integrated stress response (ISR) centered on ATF3. This ATF3-mediated ISR suppresses NRF2 expression, compromising their ability to counteract oxidative stress and ultimately triggering ferroptosis. Critically, we show that co-treatment with the ISR inhibitor ISRIB and NK cells not only prevents NK cell ferroptosis but also synergizes to enhance tumor cell killing. These findings provide novel insights into the mechanisms driving NK cell exhaustion within the TME and identify ISR inhibition as a promising therapeutic target and intervention strategy for developing NK cell-based therapies against ovarian cancer.
肿瘤内缺乏细胞毒性效应细胞,如CD8⁺T细胞或自然杀伤(NK)细胞,会形成免疫冷肿瘤微环境(TME),导致免疫治疗反应不佳,卵巢癌中就观察到了这种情况。尽管先前的研究表明TME内的NK细胞耗竭与铁死亡有关,但其潜在机制仍不明确。本研究表明,浸润到卵巢癌TME中的NK细胞会激活以ATF3为中心的综合应激反应(ISR)。这种由ATF3介导的ISR会抑制NRF2的表达,损害其对抗氧化应激的能力,最终引发铁死亡。至关重要的是,我们发现ISR抑制剂ISRIB与NK细胞联合治疗不仅能防止NK细胞发生铁死亡,还能协同增强对肿瘤细胞的杀伤作用。这些发现为TME内驱动NK细胞耗竭的机制提供了新的见解,并确定ISR抑制是开发针对卵巢癌的基于NK细胞疗法的一个有前景的治疗靶点和干预策略。